Cited by 1,625COVID-19 Clinical Research StudiesRespiratory Support and MechanismsSARS-CoV-2 and COVID-19 Research

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Open access

Geleris, Joshua, Sun, Yifei, Platt, Jonathan, Zucker, Jason, Baldwin, Matthew, Hripcsak, George, Labella, Angelena, Manson, Daniel K., Kubin, Christine, Barr, R. Graham, Sobieszczyk, Magdalena E., Schluger, Neil W.·2020·New England Journal of Medicine

DOI 10.1056/nejmoa2012410PMC PMC7224609

Open this paper in CoChat — free account

Abstract

BACKGROUND: Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. METHODS: We examined the association between hydroxychloroquine use and intubation or death at a large medical center in New York City. Data were obtained regarding consecutive patients hospitalized with Covid-19, excluding those who were intubated, died, or discharged within 24 hours after presentation to the emergency department (study baseline). The primary end point was a composite of intubation or death in a time-to-event analysis. We compared outcomes in patients who received hydroxychloroquine with those in patients who did not, using a multivariable Cox model with inverse probability weighting according to the propensity score. RESULTS: Of 1446 consecutive patients, 70 patients were intubated, died, or discharged within 24 hours after presentation and were excluded from the analysis. Of the remaining 1376 patients, during a median follow-up of 22.5 days, 811 (58.9%) received hydroxychloroquine (600 mg twice on day 1, then 400 mg daily for a median of 5 days); 45.8% of the patients were treated within 24 hours after presentation to the emergency department, and 85.9% within 48 hours. Hydroxychloroquine-treated patients were more severely ill at baseline than those who did not receive hydroxychloroquine (median ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen, 223 vs. 360). Overall, 346 patients (25.1%) had a primary end-point event (180 patients were intubated, of whom 66 subsequently died, and 166 died without intubation). In the main analysis, there was no significant association between hydroxychloroquine use and intubation or death (hazard ratio, 1.04, 95% confidence interval, 0.82 to 1.32). Results were similar in multiple sensitivity analyses. CONCLUSIONS: In this observational study involving patients with Covid-19 who had been admitted to the hospital, hydroxychloroquine administration was not associated with either a greatly lowered or an increased risk of the composite end point of intubation or death. Randomized, controlled trials of hydroxychloroquine in patients with Covid-19 are needed. (Funded by the National Institutes of Health.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa2012410

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Esteves-Vieira, V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
Retracted
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L. Y., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,696
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Devaux, C. A., Rolain, J., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,122
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial
Borba, M. G. S., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Brito, M., Mourão, M. P. G., Brito-Sousa, J. D., Baía-da-Silva, D., Guerra, M. V. F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8857 · Cited by 1,038
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trialPreprint
Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., & Zhang, Z. (2020) · medRxiv · doi:10.1101/2020.03.22.20040758 · Cited by 861
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
Chen, J., Liu, D., Liu, L., Liu, P., Xu, Q., Xia, L., Ling, Y., Huang, D. F., Song, S., Zhang, D., et al. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.03.03 · Cited by 662
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Fantini, J., Scala, C. D., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105960 · Cited by 566
Mechanism of action of hydroxychloroquine as an antirheumatic drug
Fox, R. I. (1993) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(10)80012-5 · Cited by 430
Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities
Biot, C., Daher, W., Leleu‐Chavain, N., Fandeur, T., Khalife, J., Dive, D., & Clercq, E. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601856 · Cited by 318

Flagged first, then by citations

Show all 17 references

Sorted by citations

Items 801–900 of 1,000

Spotlight on 4‐substituted quinolines as potential anti‐infective agents: Journey beyond chloroquine
Goyal, A., Kharkwal, H., Piplani, M., Singh, Y., Murugesan, S., Aggarwal, A. K., Kumar, P., & Chander, S. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200361 · Cited by 12
"Slow research" in the time of Covid-19
Ranganathan, S. (2020) · Indian Journal of Medical Ethics · doi:10.20529/ijme.2020.072 · Cited by 12
Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis
Ullah, W., Abdullah, H. M. A., Roomi, S., Sattar, Y., Almas, T., Gowda, S. N., Saeed, R., Mukhtar, M., Ahmad, A., Oliver, T., et al. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4233 · Cited by 12
Both Chloroquine and Lopinavir/Ritonavir Are Ineffective for COVID‐19 Treatment and Combined Worsen the Pathology: A Single‐Center Experience with Severely Ill Patients
Sevilla-Castillo, F., Roque-Reyes, O. J., Romero-Lechuga, F., Gómez-Núñez, M. F., Castillo-López, M., Medina-Santos, D., Román, P. O., Flores-Hernández, J. R., Méndez-Coca, J. D., Montaño‐Olmos, D., et al. (2021) · BioMed Research International · doi:10.1155/2021/8821318 · Cited by 12
Agentes terapéuticos utilizados en 238 pacientes hospitalizados por COVID-19 y su relación con la mortalidad
Rivera‐Izquierdo, M., Valero-Ubierna, M. D. C., R-delAmo, J. L., Fernández-García, M. Á., Martínez-Diz, S., Tahery-Mahmoud, A., Rodríguez-Camacho, M., Gámiz-Molina, A. B., Gyengo, N. B., Gámez-Baeza, P., et al. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.06.025 · Cited by 11
Development and utility of a SARS-CoV-2 pseudovirus assay for compound screening and antibody neutralization assays
Manu, A. A., Owusu, I. A., Oyawoye, F. O., Languon, S., Ibrahim, B. A., Tawiah-Eshun, S., Quaye, O., Donkor, J. K., Paemka, L., Amegatcher, G., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31392 · Cited by 11
Sustainable Natural Deep Eutectic Solvent-Mediated Synthesis of Magnesium Zirconate Nanoparticles: A Photocatalyst for the Degradation of Anti-Viral Drug
Sriram, B., Sherlin, A., V, Wang, S., Jackulinflora, P., & George, M. (2024) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.4c03383 · Cited by 11
Publishing in the time of pandemic: Editorial policy of a dermatology journal during COVID-19
Panda, S. (2020) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/ijdvl.ijdvl_704_20 · Cited by 11
Exploring Repurposing Potential of Existing Drugs in the Management of COVID-19 Epidemic: A Critical Review
Chakraborty, D., Debnath, F., Biswas, S., Bhatta, M., Ganguly, S., Deb, A. K., Saha, M. K., & Dutta, S. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4241 · Cited by 11
The COVID‐19 pandemic: A community approach
Cravedi, P., Schold, J. D., Safa, K., Kates, O. S., Elfadawy, N., Mannon, R. B., Shah, M. B., Hammond, S. P., Avery, R. K., Guerrero-Miranda, C. Y., et al. (2020) · Clinical Transplantation · doi:10.1111/ctr.14059 · Cited by 11
Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
Gupta, A., & Malviya, A. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138585 · Cited by 11
Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis
Hong, T. S., Gonzalez, J., Nahass, R., & Brunetti, L. (2020) · Pharmacy · doi:10.3390/pharmacy8040208 · Cited by 11
An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy
Celotto, S., Veronese, N., Barbagallo, M., Ometto, F., Smith, L., Pardhan, S., Barnett, Y., Ilie, P. C., Soysal, P., Lagolio, E., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.018 · Cited by 11
COVID-19 in Kidney Transplant Patients From a Large UK Transplant Center: Exploring Risk Factors for Disease Severity
Sran, K., Olsburgh, J., Kassimatis, T. I., Clark, K., Gökmen, R., Hilton, R. M., Shah, S., Shaw, C., Farmer, C., Kilbride, H. S., et al. (2020) · Transplantation Proceedings · doi:10.1016/j.transproceed.2020.11.007 · Cited by 11
Therapy of patients with COVID-19: clinical studies and recommendations in different countries
Зайков, С. В. (2020) · Infusion & Chemotherapy · doi:10.32902/2663-0338-2020-4-5-12 · Cited by 11
Lung Transplantation in Patients With COVID-19-The Early National Experience
Florissi, I., Etchill, E. W., Barbur, I., Giuliano, K. A., Merlo, C. A., & Bush, E. L. (2022) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2022.08.008 · Cited by 11
Association Between Hypertension and New-Onset Non-Alcoholic Fatty Liver Disease in Chinese Non-Obese People: A Longitudinal Cohort Study
Yang, D., Lan, J., Cen, J., Han, Y. Y., & Hu, H. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s396011 · Cited by 11
Proximal vs Extensive Repair in Acute Type A Aortic Dissection Surgery
Liu, H., Zhang, Y., Ding, X.-H., Qian, S.-C., Sun, M., Hamzah, A.-W., Gao, Y., Shao, Y., Li, H., Wang, K., et al. (2023) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2023.04.019 · Cited by 11
A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments
Winterstein, A. G., Ehrenstein, V., Brown, J. S., Stürmer‎, T., & Smith, M. Y. (2023) · Diabetes Care · doi:10.2337/dc22-2037 · Cited by 11
Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy
Pati, S. B. B., & Houston, T. (2020) · Epilepsy Research · doi:10.1016/j.eplepsyres.2020.106399 · Cited by 11
Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Sharma, A. K., Sharma, V., Arun, S., Pallikkuth, S., & Sharma, A. K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200711153829 · Cited by 11
Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure
Rakedzon, S., Khoury, Y., Rozenberg, G., & Neuberger, A. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10416 · Cited by 11
Susceptibility to COVID‐19 in Patients Treated With Antimalarials: A Population‐Based Study in Emilia‐Romagna, Northern Italy
Salvarani, C., Mancuso, P., Gradellini, F., Viani, N., Pandolfi, P., Reta, M., Carrozzi, G., Sandri, G., Bajocchi, G., Galli, E., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41475 · Cited by 11
Posicionamento sobre Uso de Antiplaquetários e Anticoagulantes nos Pacientes Infectados pelo Novo Coronavírus (COVID-19) – 2020
Soeiro, A. D. M., Leal, T. D. C. A. T., Pereira, M. D. P., Lima, E. G., Figueiredo, A. C. B. S., Petriz, J. L. F., Précoma, D. B., & Junior, C. V. S. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200424 · Cited by 11
Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression
Georgiev, T., & Angelov, A. K. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i17.3669 · Cited by 11
COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients
Bianco, M., Biolè, C., Campagnuolo, S., Pietrangiolillo, F., Spirito, A., Galluzzo, A., Nuñez-Gil, I. J., Destefanis, P., Luciano, A., Carvalho, P., et al. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100637 · Cited by 11
Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
Campbell, C. M., Guha, A., Haque, T. Z., Neilan, T. G., & Addison, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092935 · Cited by 11
Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection
Gautam, S. S., Gautam, C. S., Garg, V. K., & Singh, H. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1832889 · Cited by 11
An overview on the use of antivirals for the treatment of patients with COVID19 disease
Malinis, M. F., McManus, D. S., Davis, M., & Topal, J. E. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1847270 · Cited by 11
COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020
Acosta, A. M., Mathis, A. L., Budnitz, D. S., Geller, A. I., Chai, S. J., Alden, N. B., Meek, J. I., Anderson, E. J., Ryan, P., Kim, S., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa528 · Cited by 11
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?—The IDENTIFY Trial
Burdick, H., Lam, C., Mataraso, S. J., Siefkas, A. C., Braden, G. L., Dellinger, R. P., McCoy, A., Vincent, J., Green‐Saxena, A., Barnes, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123834 · Cited by 11
Therapeutic approaches against coronaviruses acute respiratory syndrome
Servidio, C., & Stellacci, F. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.691 · Cited by 11
COVID-19: What Do Rheumatologists Need to Know?
Fitzgerald, G. E., Maguire, S., & Haroon, N. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-020-00971-y · Cited by 11
Hydroxychloroquine in the treatment of COVID-19 disease: a systematic review and meta-analysis
Manzo-Toledo, A., Rosas, R. T., Zerón, H. M., Arriaga‐Pizano, L., & Argueta‐Figueroa, L. (2021) · Medical Journal of Indonesia · doi:10.13181/mji.oa.205012 · Cited by 11
The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort
Abdulrahman, A., AlSayed, I., Almadhi, M. A., AlArayed, J., Mohammed, S., Sharif, A. K., Alansari, K., AlAwadhi, A. I., & AlQahtani, M. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00397-8 · Cited by 11
Role of Chest CT in COVID-19
Malguria, N., Yen, L.-H., Lin, T., Hussein, A., & Fishman, E. K. (2021) · Journal of Clinical Imaging Science · doi:10.25259/jcis_138_2020 · Cited by 11
Comparative effectiveness of endoscopic versus microscopic transsphenoidal surgery for patients with growth hormone secreting pituitary adenoma: An emulated trial
Qiao, N., Shen, M., He, W., He, M., Zhang, Z., Ye, H., Shou, X., Wang, Y., & Zhao, Y. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106781 · Cited by 11
Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes
Guo, J., Lin, W.-H. W., Zucker, J. E., Nandakumar, R., Uhlemann, A., Wang, S., & Shivakoti, R. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac003 · Cited by 11
Self-citation
Pulmonary Delivery of Aerosolized Chloroquine and Hydroxychloroquine to Treat COVID-19: In Vitro Experimentation to Human Dosing Predictions
Kolli, A. R., Semren, T. Ž., Bovard, D., Majeed, S., van der Toorn, M., Scheuner, S., Guy, P. A., Kuczaj, A. K., Mazurov, A. A., Frentzel, S., et al. (2022) · The AAPS Journal · doi:10.1208/s12248-021-00666-x · Cited by 11
The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure
Al‐Dorzi, H. M., Al‐Dawood, A., Al-Hameed, F. M., Burns, K. E. A., Mehta, S., Jose, J., Alsolamy, S. J., Abdukahil, S. A., Afesh, L. Y., Alshahrani, M. S. S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12336-9 · Cited by 11
Lung Transplantation in Coronavirus-19 Patients
Cerier, E. J., Lung, K. C., Kurihara, C., & Bharat, A. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.11.017 · Cited by 11
Prevalence and characteristics of antibiotic prescription for acute COVID-19 patients in Japan
Hamada, S., Tokuda, Y., Honda, H., Watari, T., Suzuki, T., Moromizato, T., Narita, M., Taniguchi, K., & Shibuya, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-26780-0 · Cited by 11
Therapeutic status of hydroxychloroquine in COVID-19: A review
Kaushal, S., Kaur, K., & Kaushal, I. G. (2020) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_313_20 · Cited by 11
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
Li, C., & Cheng, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01969 · Cited by 11
Management of liver disease patients in different clinical situations during COVID-19 pandemic
Zaky, S., Alboraie, M. A. A., Badry, M. E., Metwally, M. A., Abdelaziz, A., Fouad, Y. M., Abd-Elsalam, S. M., Mahmoud, A., Shiha, G. E.-S., Baki, A. A., et al. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00091-x · Cited by 11
Anakinra and Intravenous IgG versus Tocilizumab in the Treatment of COVID-19 PneumoniaPreprint
Zantah, M., Castillo, E. D., Gangemi, A. J., Patel, M., Chowdhury, J. M., Verga, S. R., Abramian, O., Zheng, M., Lu, K., Lau, A. C. W., et al. (2020) · medRxiv · doi:10.1101/2020.09.11.20192401 · Cited by 11
The Effect of Early Hydroxychloroquine-based Therapy in COVID-19 Patients in Ambulatory Care Settings: A Nationwide Prospective Cohort StudyPreprint
Sulaiman, T., Mohana, A., Alawdah, L. S., Mahmoud, N., Hassanein, M., Wani, T. A., Alfaifi, A., Alenazi, E., Radwan, N. M., AlKhalifah, N., et al. (2020) · medRxiv · doi:10.1101/2020.09.09.20184143 · Cited by 11
Monocyte-Driven Atypical Cytokine Storm and Aberrant Neutrophil Activation as Key Mediators of COVID19 Disease SeverityPreprint
Vanderbeke, L., Mol, P. V., Herck, Y. V., Smet, F. D., Humblet‐Baron, S., Martinod, K., Antoranz, A., Arijs, I., Boeckx, B., Bosisio, F. M., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3646561 · Cited by 11
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations
Read, S. H., Khachatryan, A., Chandak, A. N., Casciano, R., Hodgkins, P., Haubrich, R., & Mozaffari, E. (2021) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2021-0179 · Cited by 11
The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin
Simmering, J. E., Polgreen, L. A., Polgreen, P. M., Teske, R., Comellas, A. P., & Carter, B. L. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2445 · Cited by 10
Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City
Gulick, R. M., Sobieszczyk, M. E., Landry, D. W., & Hollenberg, A. N. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142151 · Cited by 10
Self-citation
Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort
Jourdes, A., Lafaurie, M., Martin‐Blondel, G., Delobel, P., Faruch, M., Charpentier, S., Minville, V., Silva, S., Thalamas, C., Sommet, A., et al. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.08.006 · Cited by 10
Sudden Cardiac Death in Haemodialysis Patients under Hydroxychloroquine Treatment for COVID-19: A Report of Two Cases
Murt, A., Dinçer, M. T., & Karaca, C. (2020) · Blood Purification · doi:10.1159/000511392 · Cited by 10
Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection
Chivukula, R. R., Maley, J. H., Dudzinski, D. M., Hibbert, K. A., & Hardin, C. C. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620969132 · Cited by 10
Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study
Hardesty, A., Pandita, A., Vieira, K., Rogers, R., Merhi, B., Osband, A. J., Aridi, J., Shi, Y., Bayliss, G. P., Cosgrove, C. J., et al. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.01.002 · Cited by 10
Clinical, biological and radiological features, 4-week outcomes and prognostic factors in COVID-19 elderly inpatients
Palich, R., Wakim, Y., Itani, O., Paccoud, O., Boussouar, S., Lévy-Soussan, M., Soulié, C., Godefroy, N., & Bleibtreu, A. (2021) · Infectious Diseases Now · doi:10.1016/j.idnow.2020.12.004 · Cited by 10
Facteurs associés à la survenue de la détresse respiratoire aiguë et au décès chez des patients atteints de COVID-19 au Burkina Faso
Ouédraogo, A. R., Bougma, G., Baguiya, A., Sawadogo, A., Kabore, P., Minougou, C. J., Diendéré, É. A., Maiga, S., Agbaholou, C. R., Héma, A., et al. (2021) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2021.02.001 · Cited by 10
Balancing clinical evidence in the context of a pandemic
Adashek, J. J., & Kurzrock, R. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00834-6 · Cited by 10
Genetic Structure, Transmission, Clinical Characteristics, Diagnosis, Treatment and Prevention of Coronavirus Disease 2019 (COVID-19): A Review
Al-Mayyahi, R. S., & Al-Tumah, W. A. G. (2021) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol30iss1pp56-65 · Cited by 10
Computational Chemistry to Repurposing Drugs for the Control of COVID-19
Hassanzadeganroudsari, M., Ahmadi, A., Rashidi, N., Hossain, M. M., Habib, A., & Apostolopoulos, V. (2021) · Biologics · doi:10.3390/biologics1020007 · Cited by 10
COVID‐19 in lung transplant recipients: A single‐center experience
Türkkan, S., Beyoğlu, M. A., Şahin, M. F., Yazıcıoğlu, A., Tekce, Y. T., & Yekeler, E. (2021) · Transplant Infectious Disease · doi:10.1111/tid.13700 · Cited by 10
Stem cell therapy for COVID-19 pneumonia
Kebria, M. M., Milan, P. B., Peyravian, N., Kiani, J., Khatibi, S., & Mozafari, M. (2022) · Molecular Biomedicine · doi:10.1186/s43556-021-00067-8 · Cited by 10
Association of metabolic syndrome with depression in US adults: A nationwide cross-sectional study using propensity score-based analysis
Zhang, L., Zhou, Q., Shao, L. H., Hu, X. Q., Wen, J., & Xia, J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1081854 · Cited by 10
Repurposing Polyether Ionophores as a New-Class of Anti-SARS-Cov-2 Agents as Adjunct Therapy
Gurukkalot, K., & Rajendran, V. (2023) · Current Microbiology · doi:10.1007/s00284-023-03366-1 · Cited by 10
Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials
Abrams-Downey, A. J., Saabiye, J., & Vidaurrazaga, M. M. (2020) · European Urology Focus · doi:10.1016/j.euf.2020.05.019 · Cited by 10
Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia
Mohana, A., Sulaiman, T., Mahmoud, N., Hassanein, M., Alfaifi, A., Alenazi, E., Radwan, N. M., AlKhalifah, N., Elkady, E., Almohaizeie, A., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.031 · Cited by 10
Challenges of Shared Decision Making in Older Patients with COVID ‐19
Dhand, A., Forman, L., Vegunta, R., Aronow, W. S., & Nabors, C. C. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16991 · Cited by 10
Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)
Gutiérrez, M. D. M., Mur, I., Mateo, G. M., Vidal, F., & Domingo, P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1887140 · Cited by 10
ENSINO DE CIÊNCIAS NA ERA DA PÓS-VERDADE: CONSIDERAÇÕES ACERCA DO DISCURSO PRESENTE EM FAKE NEWS
de Britto, D. M. C., & de Mello, I. C. (2022) · REAMEC - Rede Amazônica de Educação em Ciências e Matemática · doi:10.26571/reamec.v10i1.13007 · Cited by 10
SARS-CoV-2 infections in patients with autoimmune blistering disorders: A case series and retrospective analysis
Breglio, K. F., Sarver, M. M., Hall, R. P., & Marano, A. L. (2022) · JAAD International · doi:10.1016/j.jdin.2022.01.003 · Cited by 10
Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro
Song, Y., Deng, Y., Wang, H., Bei, Z., Gu, H., Zhao, H., Wang, H., Zhang, D., Xu, L., Wang, B., et al. (2022) · Molecules · doi:10.3390/molecules27030712 · Cited by 10
Chemistry of polyhalogenated nitrobutadienes, 17: Efficient synthesis of persubstituted chloroquinolinyl-1 H -pyrazoles and evaluation of their antimalarial, anti-SARS-CoV-2, antibacterial, and cytotoxic activities
Zapol’skii, V. A., Berneburg, I., Bilitewski, U., Dillenberger, M., Becker, K., Jungwirth, S., Shekhar, A., Krueger, B., & Kaufmann, D. E. (2022) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.18.54 · Cited by 10
The Association Between Congestive Heart Failure and One-Year Mortality After Surgery in Singaporean Adults: A Secondary Retrospective Cohort Study Using Propensity-Score Matching, Propensity Adjustment, and Propensity-Based Weighting
Han, Y. Y., Hu, H., Liu, Y., Li, Q., Huang, Z., Wang, Z., Liu, D., & Wei, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.858068 · Cited by 10
COVID‐19 in pancreas transplant recipients
Dube, G. K., Husain, S. A., McCune, K. R., Sandoval, P. R., Ratner, L. E., & Cohen, D. J. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13359 · Cited by 10
Risk factors associated with the need for oxygen therapy in patients with COVID-19
Noh, C. S., Kim, W., & Baek, M. S. (2021) · Medicine · doi:10.1097/md.0000000000025819 · Cited by 10
Concordance between the results of randomized and non-randomized interventional clinical trials assessing the efficacy of drugs for COVID-19: a cross-sectional study
Shepshelovich, D., Yahav, D., Ben‐Ami, R., Goldvaser, H., & Tau, N. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab163 · Cited by 10
The Evolution of Clinical Knowledge During COVID-19: Towards a Global Learning Health System
Verspoor, K. M. (2021) · Yearbook of Medical Informatics · doi:10.1055/s-0041-1726503 · Cited by 10
Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trialPreprint
Cavalcanti, A. B., Zampieri, F. G., Azevedo, L. C., Rosa, R. G., Avezum, Á., Veiga, V. C., Lópes, R. D., Kawano-Dourado, L. B., Damiani, L. P., Pereira, A. J., et al. (2020) · medRxiv · doi:10.1101/2020.05.19.20106997 · Cited by 10
Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in FrancePreprint
Zureik, M., Baricault, B., Vabre, C., Semenzato, L., Drouin, J., Cuenot, F., Penso, L., Herlemont, P., Sbidian, É., Weill, A., et al. (2020) · medRxiv · doi:10.1101/2020.07.28.20160630 · Cited by 10
Will Evidence-based Medicine Survive the COVID-19 Pandemic?
Neto, A. S., & Hodgson, C. L. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202006-587ed · Cited by 10
Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
Xu, J., & Cao, B. (2021) · European Respiratory Journal · doi:10.1183/13993003.02002-2021 · Cited by 10
Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
Dabbous, H. M., El-Sayed, M. H., Assal, G. E., Elghazaly, H. A., Ebeid, F. S. E., Sherief, A. F., Elgaafary, M., Fawzy, E., Hassany, S. M., Riad, A. R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98683-5 · Cited by 10
Retracted
Drug-Drug Interactions in Patients with COVID-19: A Retrospective Study at a Tertiary Care Hospital in Eastern India
Manjhi, P. K., Kumar, R., Priya, A., & Rab, I. (2021) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2021.16.2.163 · Cited by 10
Postinduction Hypotension and Adverse Outcomes in Older Adults Undergoing Transcatheter Aortic Valve Replacement: A Retrospective Cohort Study
Ni, T., Yao, Y., Zhou, X., Lv, T., Zou, J.-C., Luo, G., Yang, J.-T., Sun, D., Gao, Q., Wang, T., et al. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s487629 · Cited by 9
Emulating Target Trials to Study Perioperative and Critical Care Interventions with Observational Data: Promise and Limitations
Messinger, C. J., Bateman, B. T., & Wanis, K. N. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005308 · Cited by 9
A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance
Ahn, B. Y., Kang, C. K., Seo, J. D., Choe, P. G., Song, S. H., Park, W. B., Park, S., Kim, N. J., & Oh, M. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e231 · Cited by 9
Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19
Rasouli, M., Vakilian, F., & Ranjbari, J. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666201221151853 · Cited by 9
Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
Lagier, J., Million, M., Cortaredona, S., Delorme, L., Colson, P., Fournier, P., Brouqui, P., Raoult, D., & Parola, P. (2022) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s364022 · Cited by 9
A Narrative Review of Emerging Therapeutics for COVID-19
Willis, V. C., Arriaga, Y. E., Weeraratne, D., Reyes, F. L., & Jackson, G. P. (2020) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2020.07.004 · Cited by 9
TREATMENT WITH HYDROXYCHLOROQUINE IN PATIENTS WITH COVID-19. EXPERIENCE OF A NEUROLOGY DEPARTMENT
Davidescu, E. I. (2020) · FARMACIA · doi:10.31925/farmacia.2020.4.3 · Cited by 9
A Focus on the Nowadays Potential Antiviral Strategies in Early Phase of Coronavirus Disease 2019 (Covid-19): A Narrative Review
Monari, C., Gentile, V., Camaioni, C., Marino, G., Coppola, N., & Vanvitelli COVID-19 group (2020) · Life · doi:10.3390/life10080146 · Cited by 9
Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection
Hoang, P. T., Hurtubise, B., & Muppidi, S. (2020) · Neurology · doi:10.1212/wnl.0000000000010651 · Cited by 9
QT interval measurement with portable device during COVID-19 outbreak
González, N. T., Álvarez-Acosta, L., Valdivia-Miranda, D., Plasencia, A. I., Cáceres, V. B., Zambrano, M. R., & Hernández-Afonso, J. S. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100644 · Cited by 9
First Wave in COVID-19 Pandemic: A Single Center Experience
Karakoç, Z. Ç., Şimşek, B. P., Asil, R., Dodurgali, R., Caliskaner, F., Ozsari, A., Tuğrul, S., & Ece, F. (2020) · Klimik Dergisi/Klimik Journal · doi:10.5152/kd.2020.47 · Cited by 9
The Novel Coronavirus and Inflammation
George, J. A., & Mayne, E. S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59261-5_11 · Cited by 9
The therapeutic effect and safety of the drugs for COVID-19
Qiu, R., Li, J., Xiao, Y., Gao, Z., Weng, Y., Zhang, Q., Wang, C., Gong, H., & Li, W. (2021) · Medicine · doi:10.1097/md.0000000000025532 · Cited by 9
COVID-19 desde una perspectiva cardiovascular
Bryce, A., Bryce‐Alberti, M., Portmann-Baracco, A., Urquiaga-Calderón, J., Vigna, C. A. L., & Valdivia, E. A. (2020) · Archivos de cardiología de México · doi:10.24875/acm.20000304 · Cited by 9
Organoid technology and lung injury mouse models evaluating effects of hydroxychloroquine on lung epithelial regeneration
Zhao, F., Wang, J., Wang, Q., Hou, Z., Zhang, Y., Li, X., Wu, Q., & Chen, H. (2022) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.21-0168 · Cited by 9
Efficacy of COVID-19 treatments among geriatric patients: a systematic review
Senderovich, H., Vinoraj, D., Stever, M., & Waicus, S. (2022) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361221095666 · Cited by 9
Consequences of COVID-19 on the cardiovascular and renal systems
Zhu, Y., Zhang, X., & Peng, Z. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.07.011 · Cited by 9

Authors: Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., Sobieszczyk, M. E., & Schluger, N. W.
Affiliations: Columbia University Irving Medical Center (US)
Corresponding author: Schluger, Neil W.
ORCID: Geleris, Joshua
Sun, Yifei
Platt, Jonathan
Zucker, Jason
Baldwin, Matthew
Hripcsak, George
Manson, Daniel K.
Kubin, Christine
Barr, R. Graham
Sobieszczyk, Magdalena E.
Schluger, Neil W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-06-18
Volume: 382
Issue: 25
Pages: 2411-2418
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa2012410
PMC: PMC7224609
OpenAlex: W3023346879
Cited by: 1,625
References: 17
Citations by year: 2026: 16 · 2025: 23 · 2024: 57 · 2023: 80 · 2022: 167 · 2021: 440 · 2020: 839
FWCI: 49.99
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (RO1-HL077612, RO1-HL093081, RO1-HL121270, RO1-LM006910)
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (200-2009-32593)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords: hydroxychloroquine, COVID-19 pandemic, mechanical ventilation, intubation, mortality, hospitalized patients, antimalarial drugs, treatment efficacy, propensity score weighting, SARS-CoV-2
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Adult, Aged, Aged, 80 and over, Female, Hospitalization, Humans, Hydroxychloroquine, Intubation, Male, Middle Aged, New York City, Pneumonia, Viral, Treatment Failure, Coronavirus Infections, Propensity Score, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks